Abstract
Salient features like strapping targeted drug delivery, improvisation in efficacy and safety profiles, extraordinary distinctiveness in physicochemical properties, etc. made nanopharmaceuticals immensely popular among formulators over the past few years. Nanoformulations, which are legacy of applications of nanotechnology, concern the use of specifically engineered materials to fabricate new therapeutic and diagnostic techniques. Exceptional physicochemical properties make nanoformulations more powerful in combating serious concerns that were associated with conventional formulation systems. Improved nanocarriers like nanoliposomes, nanoparticles, dendrimers, quantum dots, nanoemulsions and nanosuspensions came up with great control over controlled drug delivery, thus consistently emerging as most promising technology in this era. Nanotechnology presents a wide range of quality from diagnostic applications in early detection of diseases such as cancer to prolonged lowering of blood glucose levels in hyperglycaemia. Additionally, nanoformulation system has also gained success in the management of diseases by incorporating both imaging and therapeutic competence. A comprehensive assessment of each nanoformulation is necessary to enhance our current gamut in nanopharmaceuticals. With this aim, this chapter delivers a cursory detail on major nanopharmaceutical formulation systems and their roles in various medical conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbasi E, Aval SF, Akbarzadeh A, Milani M, Nasrabadi HT, Joo SW, Hanifehpour Y, Koshki KN, Asl RP (2014) Dendrimers: synthesis, applications, and properties. Nanoscale Res Lett 9(1):247
Abreu AS, Castanheira EMS, Queiroz M, Ferreira P, Silva L, Pinto E (2011) Nanoliposomes for encapsulation and delivery of the potential antitumoral methyl 6-methoxy-3-(4-methoxyphenyl)-1H-indole-2-carboxylate. Nanoscale Res Lett 6(1):482
Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E (2002) Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A 99(20):12617–12621
Akhtar J, Siddiqui HH, Fareed S, Aqil M (2016) Nanoemulsion: for improved oral delivery of repaglinide. Drug Deliv 23(6):2026–2034
Aldana J, Wang YA, Peng X (2001) Photochemical instability of CdSe nanocrystals coated by hydrophilic thiols. J Am Chem Soc 123:8844–8850
Alivisatos AP (2004) The use of nanocrystals in biological detection. Nat Biotechnol 22:47–52
Aslan B, Ozpolat B, Sood AK, Berestein GL (2013) Nanotechnology in cancer therapy. J Drug Target 21(10):904–913
Babu A, Templeton AK, Munshi A, Ramesh R (2014) Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer. AAPS Pharm Sci Tech 15(3):709–721
Bahshi L, Freeman R, Gill R, Willner I (2009) Optical detection of glucose by means of metal nanoparticles or semiconductor quantum dots. Small 5:676–680
Baloch J, Sohail MF, Sarwar HS, Kiani MH, Khan GM, Jahan S, Rafay M, Chaudhry MT, Yasinzai M, Shahnaz G (2019) Self-Nanoemulsifying Drug Delivery System (SNEDDS) for improved oral bioavailability of chlorpromazine: in vitro and in vivo evaluation. Medicina (Kaunas) 55(5):210
Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–252
Barenholz Y (2007) Amphipathic weak base loading into preformed liposomes having a transmembrane ammonium ion gradient: from the bench to approved DOXIL. In: Liposome technology: entrapment of drugs and other materials into liposomes, New York: Informa Healthcare. (3rd edn) vol 2, pp 1–25
Barenholz Y (2012) Doxil® – the first FDA-approved nano-drug: lessons learned. J Control Release 160(2):117–134
Barenholz Y, Amselem S, Goren D, Cohen R, Gelvan D, Samuni A, Golden EB, Gabizon A (1993) Stability of liposomal doxorubicin formulations: problems and prospects. Med Res Rev 13(4):449–491
Beaurepaire E, Buissette V, Sauviat MP, Giaume D, Lahlil K, Mercuri A (2004) Functionalized fluorescent oxide nanoparticles: artificial toxins for sodium channel targeting and imaging at the single-molecule level. Nano Lett 4(11):2079–2083
Behr JP (1997) The proton sponge: a trick to enter cells the viruses did not exploit. Chimia 51:34–36
Bera D, Qian L, Tseng T, Holloway P (2010) Quantum dots and their multimodal applications: a review. Materials (Basel) 3(4):2260–2345
Bernstein DI, Stanberry LR, Sacks S, Ayisi NK, Gong YH, Ireland J, Mumper RJ, Holan G, Matthews B, McCarthy T, Bourne N (2003) Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes. Antimicrob Agents Chemother 47(12):3784–3788
Bielinska AU, Kukowska-Latallo JF, Baker JR Jr (1996) Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res 24:2176–2182
Bielinska AU, Kukowska-Latallo JF, Baker JR Jr (1997) The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA. Biochim Biophys Acta 1353:180–190
Binnewies M, Edward W, Kersten RK, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Rosenberg SO, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, Woodhouse EC, Weinberg RA, Krummel MF (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541–550
Bosman AW, Janssen HM, Meijer EW (1999) About dendrimers: structure, physical properties, and applications. Chem Rev 99(7):1665–1688
Bruchez M, Moronne M, Gin P, Weiss S, Alivisatos AP (1998) Semiconductor nanocrystals as fluorescent biological labels. Science 281:2013–2016
Caravan P (2006) Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 35:512–523
Chan WC and Nie S (1998) Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281(5385): 2016–2018
Chen W, Turro NJ, Tomalia DA (2000) Using ethidium bromide to probe the interactions between DNA and dendrimers. Langmuir 16:15–19
Chingunpituk J (2007) Nanopsuspention technology for drug delivery. Walailak J Sci Technol 4(2):139–153
Choi SH, Lee JH, Choi SM, Park TG (2006) Thermally reversible pluronic/heparin nanocapsules exhibiting 1000-fold volume transition. Langmuir 22(4):1758–1762
Choi SR, Britigan BE, Narayanasamy P (2019) Treatment of Virulent Mycobacterium tuberculosis and HIV coinfected macrophages with gallium nanoparticles inhibits pathogen growth and modulates macrophage cytokine production. mSphere 24(4). pii: e00443–19
Deng H, Liu Q, Wang X, Huang R, Liu H, Lin Q, Zhou X, Xing D (2017) Quantum dots-labeled strip biosensor for rapid and sensitive detection of microRNA based on target-recycled nonenzymatic amplification strategy. Biosens Bioelectron 87:931–940
Din F, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A (2017) Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine 12:7291–7309
Deoli M (2012) Nanosuspension technology for solubilizing poorly soluble drugs. International J. Drug Dev. and Research 4(4):40–49
Espinoza LC, Silva-Abreu M, Calpena AC, RodrĂguez-Lagunas MJ, Fábrega MJ, Garduño-RamĂrez ML, Clares B (2019) Nanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases. Nanomedicine 19:115–125
Fofaria NM, Qhattal HS, Liu X, Srivastava SK (2016) Nanoemulsion formulations for anti-cancer agent piplartine – characterization, toxicological, pharmacokinetics and efficacy studies. Int J Pharm 498(1–2):12–22
Forssen EA, Tökès ZA (1981) Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity. Proc Natl Acad Sci U S A 78(3):1873–1877
Gabizon AA, Barenholz Y (2010) Method for drug loading in liposomes. Google Patents
Ganta S, Singh A, Kulkarni P, Keeler AW, Piroyan A, Sawant RR, Patel NR, Davis B, Ferris C, O'Neal S, Zamboni W, Amiji MM, Coleman TP (2015) EGFR targeted theranostic nanoemulsion for image-guided ovarian cancer therapy. Pharm Res 32(8):2753–2763
Gao X, Cui Y, Levenson RM, Chung WK, Nie S (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22(8):969–976
Gao Y, Sun M, Guo C, Yu A, Xi Y, Cui J, Lou H, Zhai G (2011) Preparation and characterization of intravenously injectable curcumin nanosuspension. Drug Deliv 18(2):131–142
Ge W, Hu P, Huang Y, Wang XM, Zhang XM, Sun YJ, Li ZS, Si SY, Sui YF (2009) The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following different administration routes. Oncol Rep 22(4):915–920
Gladwin MT, Plorde JT, Martin TR (1998) Clinical application of the Mycobacterium Tuberculosis direct test: case report, literature review and proposed clinical alogrothim. Chest 114(1):317–323
Goel S, Sachdeva M, Agarwal V (2019) Nanosuspension technology: recent patents on drug delivery and their characterizations. Recent Pat Drug Deliv Formul 13:91. https://doi.org/10.2174/1872211313666190614151615
Gong Y, Matthews B, Cheung D, Tam T, Gadawski I, Leung D, Holan G, Raff J, Sacks S (2002) Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication. Antivir Res 55(2):319–329
Gonzales J, Kossatz S, Roberts S, Pirovano G, Brand C, Medina CP, Donabedian P, de la Cruz MJ, Mulder WM, Reiner T (2018) Nanoemulsion-based delivery of fluorescent PARP inhibitors in mouse models of small cell lung cancer. Bioconjug Chem 29(11):3776–3782
Gradishar WJ, Jjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, Shaughnessy JO (2005) Phase III trial of NP albumin bound paclitaxel compared with polyethylated castor oil based paclitaxel in women with breast cancer. J Clin Oncol 23(31):7794–7803
Gupta D, Nguyen PYM (2014) Nanoparticles for superior pharmacokinestics and enhanced efficacy. J Dev Drug 3:2
Gupta A, Eral HB, Hatton TA, Doyle PS (2016) Nanoemulsions: formation, properties and applications. Soft Matter 12(11):2826–2841
Huang Q, Li L, Li L, Chen H, Dang YY, Zhang JS, Shao NM, Chang H, Zhou ZJ, Liu CY, He BW, Wei HF, Xiao JR (2016) MDM2 knockdown mediated by a triazine-modified dendrimer in the treatment of non-small cell lung cancer. Oncotarget 7(28):44013–44022
Iyisan B, Landfester K (2019) Modular approach for the design of smart polymeric nanocapsules. Macromol Rapid Commun 40(1):e1800577. https://doi.org/10.1002/marc.201800577
Jaiswal JK, Mattoussi H, Mauro JM, Simon SM (2003) Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol 21(1):47–51
Jaiswal M, Dudhe R, Sharma PK (2015) Nanoemulsion: an advanced mode of drug delivery system. Biotech 5(2):123–127
Janaszewska A, Lazniewska L, Trzepiński P, Marcinkowska M, Maculewicz K (2019) Cytotoxicity of dendrimers. Biomolecules 9(8):330
Jin X, Yijing L, Yang L, Yueqin M, Pengfei Y, Ming Y (2019) Novel redispersible nanosuspensions stabilized by co-processed nanocrystalline cellulose–sodium carboxymethyl starch for enhancing dissolution and oral bioavailability of baicalin. Int J Nanomedicine 14:353–369
Kaul G, Amiji MJ (2002) Long- circulating poly(ethyleneglycol)-modified gelatin nanoparticles for intracellular delivery. Pharm Res 19:1062–1068
Kayser O (2001) A new approach for targeting to cryptosporidium parvum using mucoadhesive nanosuspension: research and application. Int J Pharm 214:83–85
Kharia A, Singhai A, Verma R (2012) Formulation and evaluation of polymeric nanoparticles of an antiviral drug for gastroretention. Int J Pharm Sci Nanotechnol 4:1557–1562
Kim JE, Park YJ (2017a) Improved antitumor efficacy of hyaluronic acid-complexed paclitaxel nanoemulsions in treating non-small cell lung cancer. Biomol Ther (Seoul) 25(4):411–416
Kim JE, Park YJ (2017b) Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer. Int J Nanomedicine 12:645–658
Knauer N, Pashkina E, Apartsin E (2019) Topological aspects of the design of nanocarriers for therapeutic peptides and proteins. Pharmaceutics 11(2):91
Kobayashi H, Saga T, Kawamoto S, Sato N, Hiraga A, Ishimori T, Konishi J, Togashi K, Brechbiel MW (2001) Dynamic micro – magnetic resonance iimaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)64. Cancer Res 61:4966–4970
Kohno S, Otuubo T, Tanaka E, Maruyaana K, Hara K (1997) Amphotericin B encapsulated in polyethylene glycol immunoliposomes for infectious disease. Adv Drug Del Rev 24:325–329
Kotta S, Khan AW, Pramod K, Ansari SH, Sharma RK, Ali J (2012) Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv 9(5):585–598
Krittika S, Indhumathi P, VedhaHari BN, Devi DR, Yadav P (2019) Evidence of nanoemulsion as an effective control measure for fruit flies Drosophila melanogaster. Sci Rep 9:10578
Kruk ME, Gage AD, Joseph NT, Danaei G, Saisó SG, Salomon JA (2018) Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries. Lancet 392(10160):2203–2212
Kuplennik N, Lang K, Steinfeld R, Sosnik A (2019) Folate receptor alpha-modified nanoparticles for the targeting of the central nervous system. ACS Appl Mater Interfaces 11:39633. https://doi.org/10.1021/acsami.9b14659
Landers JJ, Cao Z, Lee I, Piehler LT, Myc PP, Myc A, Hamouda T, Galecki AT, Baker JR (2002) Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymers. Infect Dis 186:1222
Langer R, Folkman J (1976) Polymers for the sustained release of proteins and other macromolecules. Nature 263:797–800
Leone F, Cavalli R (2015) Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations. Expert Opin Drug Deliv 12(10):1607–1625
Leong KW, Mao HQ, Truong LVL (1998) DNA- polycation nanospheres as non viral gene delivery vehicles. J Control Release 53:183–193
Li Z, Wang Y, Wang J, Tang Z, Pounds JG, Lin Y (2010) Rapid and sensitive detection of protein biomarker using a portable fluorescence biosensor based on quantum dots and a lateral flow test strip. Anal Chem 82(16):7008–7014
Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z (2008) Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 60(15):1650–1662
Liu XX, Liu C, Catapano CV, Peng L, Zhou JH, Rocchi P (2014) Structurally flexible triethanolamine-core poly(amidoamine) dendrimers as effective nanovectors to deliver RNAibased therapeutics. Biotechnol Adv 32(4):844–852
Luganini A, Nicoletto SF, Pizzuto L, Pirri G, Giuliani A, Landolfo S, Gribaudo G (2011) Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers. Antimicrob Agents Chemother 55(7):3231–3239
Mahto R (2017) Nanoemulsion as targeted drug delivery system for cancer therapeutics. J Pharm Sci Pharmacol 3:83–97
Marcinkowska M, Stanczyk M, Janaszewska A, Sobierajska E, Chworos A, Klajnert-Maculewicz B (2019) Multicomponent conjugates of anticancer drugs and monoclonal antibody with PAMAM dendrimers to increase efficacy of HER-2 positive breast cancer therapy. Pharm Res 36(11):154
Marty JJ, Oppenheim RC, Speiser P (1978) Nanoparticles – a new colloidal drug delivery system. Pharm Acta Helv 53(1):17–23
Matea CT, Mocan T, Tabaran F, Pop T, Mosteanu O, Puia C, Iancu C, Mocan L (2017) Quantum dots in imaging, drug delivery and sensor applications. Int J Nanomedicine 12:5421–5431
Medintz IL, Uyeda HT, Goldman E, Mattoussi H (2005) Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 4:437–446
Migotto A, Carvalho VFM, Salata GC, da Silva FWM, Yan CYI, Ishida K, Costa-Lotufo LV, Steiner AA, Lopes LB (2018) Multifunctional nanoemulsions for intraductal delivery as a new platform for local treatment of breast cancer. Drug Deliv 25(1):654–667
Mittal N, Kaur G (2019) Investigations on polymeric nanoparticles for ocular delivery. Adv Polym Technol 2019:1–14
Monteagudom S, Perez-Martinez FC, Perez-Carrion MD, Guerra J, Merino S, Sanchez-Verdu MP, Cena V (2012) Inhibition of p42 MAPK using a nonviral vector-delivered siRNA potentiates the anti-tumor effect of metformin in prostate cancer cells. Nanomedicine 7(4):493–506
Moss RL (2014) Critical review, with an optimistic outlook, on boron neutron capture therapy (BNCT). Appl Radiat Isot 88:2–11
Mozafari MR (2010) Nanoliposomes: preparation and analysis. Methods Mol Biol 605:29–50
Muhamad N, Plengsuriyakarn T, Bangchang KN (2018) Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review. Int J Nanomedicine 13:3921–3935
Muller RH, Gohla S, Dingler A, Schneppe T, Wise D (2000) Handbook of pharmaceutical controlled release technology. Marcel Dekker. Large-scale production of solid-lipid nanoparticles (SLN) and nanosuspension (Dissocubes), New York, pp 359–375
Mustapha O, Kim KS, Shafique S, Kim DS, Jin SG, Seo YG, Youn YS, Oh KT, Lee BJ, Park YJ, Yong CS, Kim JO, Choi HG (2016) Development of novel cilostazol-loaded solid SNEDDS using a SPG membrane emulsification technique: physicochemical characterization and in vivo evaluation. Colloids Surf B Biointerfaces 150:216–222
Muzammil AS, Naidu VG, Harishankar N, Kishan V (2016) Albumin anchored docetaxel lipid nanoemulsion for improved targeting efficiency – preparation, characterization, cytotoxic, antitumor and in vivo imaging studies. Drug Deliv 23(4):1355–1363
Nakhlband A, Eskandani M, Omidi Y, Saeedi N, Ghaffari S, Barar J, Garjani A (2018) Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective. Bioimpacts 8(1):59–75
Nasimi P, Haidari M (2013) Medical use of nanoparticles: drug delivery and diagnosis diseases. Int J Green Nanotechnol 1:194308921350697. https://doi.org/10.1177/1943089213506978
Nasiruddin M, Neyaz MK, Das S (2017) Nanotechnology based approaches in tuberculosis treatment. Tuberc Res Treat 4920209:12
Nasr A, Gardouh A, Ghorab M (2016) Novel Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for oral delivery of olmesartan medoxomil: design, formulation, pharmacokinetic and bioavailability evaluation. Pharmaceutics 8(3):20–29
Panda BP, Kirshnamoorthy R, Hawala NK, Gowda S, Patnaik S (2018) Influence of poloxamer 188 on design and development of second generation PLGA nanocrystals of metformin HCL. Nano Biomed Eng 10(4):334–343
Pandey R, Sharma S, Khuller GK (2004) Nebulisation of liposomes encapsulated antitubercular drugsin guinea pigs. Int J Antimicrob Drugs 24(1):93–94
Pandey R, Sharma S, Khuller GK (2005) Oral solid lipid nanoparticlesbased antitubercular chemotherapy. Tuberculosis 85(5–6):415–420
Pangeni R, Choi SW, Jeon OC, Byun Y, Park JW (2016) Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation. Int J Nanomedicine 11:6379–6399
Pardridge WM (2012) Drug transport across the blood–brain barrier. J Cereb Blood Flow Metab 32(11):1959–1972
Pastar I, Stojadinovic O, Yin NC, Raminez H, Nusbaum AG, Sawaya A, Patel SB, Khalid L, Isseroff RR, Canic MT (2014) Epithilisation in wound healing: a comprehensive review. Adv Wound Care 3(7):445–464
Patel VR, Agrawal YK (2011) Nanosuspension: an approach to enhance solubility of drugs. J Adv Pharm Technol Res 2(2):81–87
Patil JS, Sarasija S (2012) Pulmonary drug delivery strategies: a concise, systematic review. Lung India 29(1):44–49
Patolsky F, Gill R, Weizmann Y, Mokari T, Banin U, Willner I (2003) Electron-transfer quenching of nucleic acid-functionalized CdSe/ZnS quantum dots by doxorubicin: a versatile system for the optical detection of DNA, aptamer–substrate complexes and telomerase activity. J Am Chem Soc 125:13918–13919
Prabhakaran D et al (2018) The changing patterns of cardiovascular diseases and their risk factors in the states of India: the global burden of disease study 1990–2016. Lancet Glob Health 6(12):e1339–e1351
Qelliny MR, Aly UF, Elgarhy OH, Khaled KA (2019) Budesonide-loaded Eudragit S 100 nanocapsules for the treatment of acetic acid-induced colitis in animal model. AAPS PharmSciTech 20(6):237
Rahman MA, Mujahid M (2018) Development of self-nanoemulsifying tablet (SNET) for bioavailability enhancement of sertraline. Braz J Pharm Sci 54. https://doi.org/10.1590/s2175-97902018000117232
Rai R, Alwani S, Badea I (2019) Polymeric nanoparticles in gene therapy: new avenues of design and optimization for delivery applications. Polymers (Basel) 11(4):745
Rajendran NK, Sundar S, Kumar D, Houreld NN, Abrahamse H (2018) A review on nanoparticle based treatment for wound healing. J Drug Deliv Sci Technol 44:421–430
Reuter JD, Myc A, Hayes MM, Gan Z, Roy R, Qin D, Yin R, Piehler LT, Esfand R, Tomalia DA, Baker JR Jr (1999) Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers. Bioconjug Chem 10:271
Riaz MK, Riaz MA, Zhang X, Lin C, Wong KH, Chen X, Zhang G, Lu A, Yang Z (2018) Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review. Int J Mol Sci 19(1):195
Roberts S, Andreou C, Choi C, Donabedian P, Jayaraman M, Edwinn C, Tang PB, Medina C, Cruz J, Mulder W, Grimm J, Kircher M, Reiner T (2018) Sonophore-enhanced nanoemulsions for optoacoustic imaging of cancer. Chem Sci 9(25):5646–5657
Sahu P, Das D, Mishra VK, Kashaw V, Kashaw SK (2017) Nanoemulsion: a novel eon in cancer chemotherapy. Mini Rev Med Chem 17(18):1778–1792
Schinazi RF, Brettreich M, Hirsch A (2003) In United States patent and trademark office; number 20030036562; www.uspto.gov
Shahba AW, Mohsin K, Alanazi FK (2012) Novel Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for oral delivery of cinnarizine: design, optimization, and in-vitro assessment. AAPS PharmSciTech 13(3):967–977
Shahba AA, Ahmed AR, Mohsin K, Abdel-Rahman SI, Alanazi FK (2017) Solidification of cinnarizine self-nanoemulsifying drug delivery systems by fluid bed coating: optimization of the process and formulation variables. Pharmazie 72(3):143–151
Shanmugapriya K, Kim H, Kang HW (2019) In vitro antitumor potential of astaxanthin nanoemulsion against cancer cells via mitochondrial mediated apoptosis. Int J Pharm 5(560):334–346
Shi R, Hong L, Wu D, Ning X, Chen Y, Lin T, Fan D, Wu K (2005) Enhanced immune response to gastric cancer specific antigen peptide by coencapsulation with CpG oligodeoxynucleotides in nanoemulsion. Cancer Biol Ther 4(2):218–224
Shinde UA, Joshi PN, Jain DD, Singh K (2019) Preparation and evaluation of N-trimethyl chitosan nanoparticles of flurbiprofen for ocular delivery. Curr Eye Res 44(5):575–582
Silva GA (2008) Nanotechnology approaches to crossing the blood brain barrier and delivery to the CNS. BMC Neurosci 9:54
Sultana S, Khan R, Kumar M, Kumar S (2012) Nanoparticle mediated drug delivery approaches for cancer targeting: a review. J Drug Target 21(2):712130
Sun Y, Wang H, Wang P, Zhang K, Geng X, Liu Q, Wang X (2019) Tumor targeting DVDMS-nanoliposomes for an enhanced sonodynamic therapy of gliomas. Biomater Sci 7(3):985–994
Tang MX, Szoka FC (1997) The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther 4:823–832
Tiyaboonchai W (2003) Chitosan nanoparticles: a promising system for drug delivery. Naresuan Univ J 11(3):51–66
Tong Y, Wang Y, Yang M, Yang J, Chen L, Chu X, Gao C, Jin Q, Gong W, Gao C (2018) Systematic development of self-nanoemulsifying liquisolid tablets to improve the dissolution and oral bioavailability of an oily drug, vitamin K1. Pharmaceutics 10(3). https://doi.org/10.3390/pharmaceutics10030096
Valizadeh A, Mikaeili H, Samiei M, Farkhani SS, Zarghami N, Kouhi M, Akbarzadeh A, Davaran S (2012) Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett 7(1):480
Wabuyele MB, Farquar H, Stryjewski W, Hammer RP, Soper SA, Cheng Y, Barany F (2003) Approaching real-time molecular diagnostics: single-pair fluorescence resonance energy transfer (spFRET) detection for the analysis of low abundant point mutations in K-ras oncogenes. J Am Chem 125:6937–6945
Wagner AM, Knipe JM, Orive G, Peppas NA (2019) Quantum dots in biomedical applications. Acta Biomater 94:44–63
Wang Z, Wn J, Zhou O, Wang Y, Chen T (2015) Berberine nanosuspension enhances hypoglycemic efficacy on streptozatocinn induced diabetic C57BL/6 mice. Evid Based Complement Altern Med 239479:5
Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, Lauterbur PC (1994) Dendrimer – based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med 31:1–8
Wu G, Barth RF, Yang W, Chatterjee M, Tjarks W, Ciesielski MJ, Fenstermaker RA (2004) Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMCC225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconjug Chem 15:185–194
World Health Organization (2018). Newsroom factsheet on cancer. Retrieved from who.int/news-room/fact-sheets/detail/cancer.
Xiao S, Zhou D, Luan P, Gu B, Feng L, Fan S, Liao W, Fang W, Yang L, Tao E, Guo R, Liu J (2016) Graphene quantum dots conjugated neuroprotective peptide improve learning and memory capability. Biomaterials 106:98–110
Xu J, Wang H, Xu L, Chao Y, Wang C, Han X, Dong Z, Chang H, Peng R, Cheng Y, Liu Z (2019) Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy. Biomaterials 207:1–9
Yan C, Gu J, Hou D, Jing H, Wang J, Guo Y, Katsumi H, Sakane T, Yamamoto A (2015) Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier. Drug Dev Ind Pharm 41(4):617–622
Yan S, Zeng X, Tang Y, Liu BF, Wang Y, Liu X (2019) Activating antitumor immunity and antimetastatic effect through polydopamine-encapsulated core-shell upconversion nanoparticles. Adv Mater 31(46):e1905825
Yücel Ç, Karatoprak GŞ, Aktaş Y (2018) Nanoliposomal resveratrol as a novel approach to treatment of diabetes mellitus. J Nanosci Nanotechnol 18(6):3856–3864
Zahoor A, Sharma S, Khuller GK (2005) Inhalable alignate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrobial Agents 26:298–303
Zhang CY, Yeh HC, Kuroki MT, Wang TH (2005) Single-quantum-dot-based DNA nanosensor. Nat Mater 4:826–831
Zhao T, Liu X, Li Y, Zhang M, He J, Zhang X, Liu H, Wang X, Gu H (2017) Fluorescence and drug loading properties of ZnSe:Mn/ZnS-Paclitaxel/SiO2 nanocapsules templated by F127 micelles. J Colloid Interface Sci 490:436–443
Zhao CY, Cheng R, Yang Z, Tian ZM (2018) Nanotechnology for cancer therapy based on chemotherapy. Molecules 23(4):826
Zhou HY, Hao JL, Wang S, Zeng Y, Zhang WS (2013) Nanoparticles in ocular drug delivery. Int J Opthalmol 6(3):390–396
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pandey, V., Kohli, S. (2020). Nanoformulations in Human Health Conditions: The Paradigm Shift. In: Talegaonkar, S., Rai, M. (eds) Nanoformulations in Human Health. Springer, Cham. https://doi.org/10.1007/978-3-030-41858-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-41858-8_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-41857-1
Online ISBN: 978-3-030-41858-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)